An Overview of the Epidemiology, Pathogenesis, Diagnosis, and Treatment of Human Parvovirus B19

References (56)

1. 1 Experimental Parvoviral Infection in Humans [DOI]
2. 2 A Viral Phospholipase A2 Is Required for Parvovirus Infectivity [DOI]
3. 3 Clinical aspects of parvovirus B19 infection [DOI]
4. 4 Intravenous Immunoglobulin Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection: A Retrospective Study of 10 Patients and Review of the Literature [DOI]
5. 5 Seroprevalence of parvovirus B19 in the German population [DOI]
6. 6 HUMAN PARVOVIRUS ARTHROPATHY [DOI]
7. 7 Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin Therapy [DOI]
8. 8 Clinical Manifestations of Human Parvovirus B19 in Adults [DOI]
9. 9 The Role of Parvovirus B19 in Aplastic Crisis and Erythema Infectiosum (Fifth Disease) [DOI]
10. 10 The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like Activity [DOI]
11. 11 Pathogenesis of human parvovirus B19 in rheumatic disease [DOI]
12. 12 Human parvovirus infection in homozygous sickle cell disease [DOI]
13. 13 Persistent B19 infection in immunocompetent individuals: implications for transfusion safety [DOI]
14. 14 The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world [DOI]
15. 15 The transfusion-associated transmission of parvovirus B19 [DOI]
16. 16 Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow [DOI]
17. 17 Slow Clearance of Human Parvovirus B19 Viremia following Acute Infection [DOI]
18. 18 Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes [DOI]
19. 19 Parvovirus B19-Induced Apoptosis of Hepatocytes [DOI]
20. 20 Conformational Changes in the VP1-Unique Region of Native Human Parvovirus B19 Lead to Exposure of Internal Sequences That Play a Role in Virus Neutralization and Infectivity [DOI]
21. 21 Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients [DOI]
22. 22 The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers [DOI]
23. 23 Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples [DOI]
24. 24 Antiviral effect of cidofovir on parvovirus B19 replication [DOI]
25. 25 Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland [DOI]
26. 26 Prevalence and genotypic characterization of human parvovirus B19 in children with hemato‐oncological disorders in North India [DOI]
27. 27 Occupational Risk of Human Parvovirus B19 Infection for School and Day-care Personnel During an Outbreak of Erythema Infectiosum [DOI]
28. 28 Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis [DOI]
29. 29 Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion Recipients [DOI]
30. 30 Occupational Risk Factors for Infection with Parvovirus B19 among Pregnant Women [DOI]
31. 31 Diagnosis and quantitative evaluation of parvovirus B19 infections by real‐time PCR in the clinical laboratory [DOI]
32. 32 Haematological response to parvovirus B19 infection in homozygous sickle-cell disease [DOI]
33. 33 Persistent parvovirus B19 infections in immunocompromised children [DOI]
34. 34 Parvovirus B19 Infection Contributes to Severe Anemia in Young Children in Papua New Guinea [DOI]
35. 35 Parvovirus B19 outbreak on an adult ward [DOI]
36. 36 Cytokines in parvovirus b19 infection as an aid to understanding chronic fatigue syndrome [DOI]
37. 37 Diagnosis and Management of Human Parvovirus B19 Infection [DOI]
38. 38 Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013 [DOI]
39. 39 Prevalence of human parvovirus (B19) and rubellavirus infections in urban and remote rural areas in northern Brazil [DOI]
40. 40 Parvovirus B19 Infection in Hospital Workers: Community or Hospital Acquisition? [DOI]
41. 41 Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M [DOI]
42. 42 Parvovirus B19 Infections and Blood Counts in Blood Donors [DOI]
43. 43 Diagnosing human parvovirus B19 infection: Guidelines for test selection [DOI]
44. 44 Nosocomial Exposure to Parvovirus B19: Low Risk of Transmission to Healthcare Workers [DOI]
45. 45 Human parvovirus B19 infection in healthcare workers [DOI]
46. 46 Seroprevalence of Antibodies to Parvovirus B19 among Children in Papua New Guinea [DOI]
47. 47 PARVOVIRUS B19-ASSOCIATED TRANSIENT RED CELL APLASIA IN CHILDREN: The Role of Bone Marrow Examination in Unusual Presentations [DOI]
48. 48 Prenatal Diagnosis of Parvovirus B19-Induced Hydrops Fetalis by Chemiluminescence In Situ Hybridization [DOI]
49. 49 A Case of Persistent Parvovirus B19 Infection with Bilateral Cartilaginous and Ligamentous Damage to the Wrists [DOI]
50. 50 Evidence of Serological Cross-Reactivity between Genotype 1 and Genotype 3 Erythrovirus Infections [DOI]
51. 51 Parvovirus B19 [DOI]
52. 52 Human Parvo Virus B19 Infection among Hospital Staff Members after Contact with Infected Patients [DOI]
53. 53 The seroprevalence of parvovirus B19 infection in pregnant women in Sudan [DOI]
54. 54 Infection and immunity for human parvovirus B19 in patients with febrile exanthema [DOI]
55. 55 Hematologic manifestations and diagnosis of parvovirus B19 infections.
56. 56 A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure [DOI]

Cited by 0

No indexed citations yet.

Related research

• Seroprevalence and Risk of Primary Maternal HCMV Infection among Pregnant Women in Taiz City, Yemen — shares topic coverage
• Serum Levels of Immunoglobulin A, G & M in Chlamydia trachomatis Infection among Primary and Secondary Infertility Patients — shares topic coverage
• Seroprevalence and Combined Profiles of IgM/IgG Antibodies against SARS-CoV-2 in Ambulatory Patients in Yaoundé, Cameroon — shares topic coverage
• Effect of Ethanolic Extract of Propolis on Humoral Immunity in Laboratory Animals — shares topic coverage
• Seroprevalence of Herpes Simplex Virus Type 2 and Associated Risk Factors among Undergraduate Female Students of Babcock University, Nigeria — shares topic coverage